Forecast the Balance Sheet | Balance Sheet For Medtronic PLC

Forecast the Balance Sheet

Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016.

Medtronic plc
Consolidated Balance Sheets
($ millions)	Apr. 29, 2016	Apr. 24, 2015
Current assets
Cash and cash equivalents	$2,988	$4,843
Investments	9,758	14,637
Accounts receivable	5,562	5,112
Inventories	3,473	3,463
Tax assets	697	1,335
Prepaid expenses and other current assets	1,234	1,454
Total current assets	23,712	30,844
Property, plant, and equipment, net	4,841	4,699
Goodwill	41,500	40,530
Other intangible assets, net	26,899	28,101
Long-term tax assets	1,383	774
Other assets	1,559	1,737
Total assets	$99,894	$106,685
Current liabilities
Short-term borrowings	$1,105	$2,434
Accounts payable	1,709	1,610
Accrued compensation	1,712	1,611
Accrued income taxes	566	935
Deferred tax liabilities	–	119
Other accrued expenses	2,185	2,464
Total current liabilities	7,277	9,173
Long-term debt	30,247	33,752
Long-term accrued compensation	1,759	1,535
Long-term accrued income taxes	2,903	2,476
Long-term deferred tax liabilities	3,729	4,700
Other long-term liabilities	1,916	1,819
Total liabilities	47,831	53,455
Shareholders’ equity
Ordinary shares	–	–
Retained earnings	53,931	54,414
Accumulated other comprehensive (loss)	(1,868)	(1,184)
Total shareholders’ equity	52,063	53,230
Total liabilities and shareholders’ equity	$99,894	$106,685

Use the following assumptions to forecast the company’s balance sheet for FY2017.

Forecasted FY2017 net income	$5,151	million
Forecasted FY2017 net sales	$36,274	million
Accounts receivable	19.3%	of net sales
Inventories	12.0%	of net sales
Tax assets	2.4%	of net sales
Prepaid expenses and other current assets	4.3%	of net sales
Long-term tax assets	4.8%	of net sales
Other assets	5.4%	of net sales
Accounts payable	5.9%	of net sales
Accrued compensation	5.9%	of net sales
Accrued income taxes	2.0%	of net sales
Other accrued expenses	7.6%	of net sales
Long-term accrued income taxes	10.1%	of net sales
Long-term deferred tax liabilities	12.9%	of net sales
Other long-term liabilities	6.6%	of net sales
Investments	No change
Goodwill	No change
Long-term accrued compensation and retirement benefits	No change
Ordinary shares	No change
Accumulated other comprehensive (loss)	No change
CAPEX	3.6%	of net sales
Depreciation expense	18.9%	of prior year PPE, net
Amortization expense in FY2016	$1,931	million
Current maturities of debt due in FY2017	$1,105	million
Current maturities of debt due in FY2018	$6,176	million
Dividend payout ratio	60.5%

Medtronic plc
Forecasted Consolidated Balance Sheet
($ millions)				EST. 2017
Current assets
Cash and cash equivalents				$Answer 1959
Investments				Answer 9758
Accounts receivable				Answer 7001
Inventories				Answer 4353
Tax assets				Answer 871
Prepaid expenses and other current assets				Answer 1560
Total current assets				Answer 21584
Property, plant, and equipment, net				Answer 5232
Goodwill				Answer 41500
Other intangible assets, net				Answer 24968
Long-term tax assets				Answer 1741
Other assets				Answer 1959
Total assets				$Answer 96984
Current liabilities
Short-term borrowings				$Answer 6176
Accounts payable				Answer 2140
Accrued compensation				Answer 2140
Accrued income taxes				Answer 725
Other accrued expenses				Answer 2757
Total current liabilities				Answer 13938
Long-term debt				Answer 24071
Long-term accrued compensation				Answer 1759
Long-term accrued income taxes				Answer 3664
Long-term deferred tax liabilities				Answer 4679
Other long-term liabilities				Answer 2494
Total liabilities				Answer 50505
Shareholders’ equity
Ordinary shares				–
Retained earnings				Answer 55966
Accumulated other comprehensive (loss)				Answer 1868
Total shareholders’ equity				Answer 54098
Total liabilities and shareholders’ equity				$Answer 104603

Post Views: 605